{"id":"W2114300639","doi":"10.1200/jco.2005.13.011","title":"Randomized Phase IIB Trial of BLP25 Liposome Vaccine in Stage IIIB and IV Non–Small-Cell Lung Cancer","year":2005,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Immunotherapy and Immune Responses","field":"Immunology and Microbiology","cited_by":421,"is_retracted":false,"has_abstract":true,"ca_institutions":"Ottawa Regional Cancer Foundation","funders":"University of Washington","keywords":"Medicine; Hazard ratio; Lung cancer; Internal medicine; Toxicity; Cyclophosphamide; Performance status; Stage (stratigraphy); Randomized controlled trial; Chemotherapy; Surgery; Gastroenterology; Confidence interval","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001264089,0.00143191,0.002214937,0.0002761495,0.0003662772,0.0008941044,0.0007196369,0.001423696,0.005613315],"category_scores_gemma":[0.0009028831,0.000500738,0.001233962,0.0003139024,0.0006910178,0.0005513379,0.0003422254,0.002372668,0.001093141],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001060242,"about_ca_system_score_gemma":0.001682598,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001494704,"about_ca_topic_score_gemma":0.003319142,"domain_scores_codex":[0.9995949,0.0002418467,0.00001921088,0.00004841558,0.00002202271,0.00007369727],"domain_scores_gemma":[0.999539,0.00009101781,0.0001117963,0.00003510338,0.00002999305,0.0001931156],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9554442,0.007055344,0.0008799739,0.0007042296,0.000758403,0.0000508605,0.00005819601,0.0009593797,0.005419664,0.0001652494,0.002498556,0.02600579],"study_design_scores_gemma":[0.9128735,0.08222681,0.001712489,0.00004172036,0.0002988293,0.00002991668,0.00002559361,0.0005976601,0.0006348882,0.0001545049,0.001394162,0.000009949347],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9750618,0.006818856,0.001019527,0.001645475,0.001119497,0.008267744,0.001701668,0.0002294232,0.004136074],"genre_scores_gemma":[0.975096,0.002961841,0.001597878,0.002589797,0.0004036038,0.009517129,0.002082825,0.00003375695,0.005717045],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005613315,"threshold_uncertainty_score":0.01877844,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05074711381612095,"score_gpt":0.4307104094668897,"score_spread":0.3799632956507687,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}